Xilio Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Xilio Therapeutics's estimated annual revenue is currently $16.1M per year.
- Xilio Therapeutics's estimated revenue per employee is $185,287
- Xilio Therapeutics's total funding is $233M.
- Xilio Therapeutics's current valuation is $398.8M. (January 2022)
Employee Data
- Xilio Therapeutics has 87 Employees.
- Xilio Therapeutics grew their employee count by -13% last year.
Xilio Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO, President | Reveal Email/Phone |
3 | Chief Legal Officer | Reveal Email/Phone |
4 | VP, Corporate Communications, Investor Relations & Patient Advocacy | Reveal Email/Phone |
5 | VP Clinical Science and Pharmacovigilance | Reveal Email/Phone |
6 | VP, Investor Relations and Corporate Communications | Reveal Email/Phone |
7 | VP, Head Human Resources | Reveal Email/Phone |
8 | SVP Clinical Operations | Reveal Email/Phone |
9 | VP, Drug Discovery | Reveal Email/Phone |
10 | SVP, IT | Reveal Email/Phone |
Xilio Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Xilio Therapeutics?
Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company?s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body ? a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.
keywords:N/A
$233M
Total Funding
87
Number of Employees
$16.1M
Revenue (est)
-13%
Employee Growth %
$398.8M
Valuation
N/A
Accelerator
Xilio Therapeutics News
Most types of targeted therapies help to treat cancer by ... For instance, Xilio Therapeutics, a biotechnology company entered into a...
Xilio Therapeutics' (NASDAQ:XLO Get Rating) lock-up period is set to end ... Xilio Therapeutics had issued 7,353,000 shares in its IPO on...
Xilio Therapeutics aims to improve on cytokine safety with a mask that stays on the therapy until it reaches the tumor microenvironment.
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.5M | 87 | -94% | $181.2M |
#2 | $19.1M | 87 | 0% | N/A |
#3 | $20M | 88 | 38% | N/A |
#4 | $8.8M | 88 | -2% | N/A |
#5 | $15.1M | 89 | -2% | N/A |